Published in Circulation on September 02, 2003
P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study). Am J Cardiol (2011) 2.39
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate. Circulation (2015) 2.12
Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhythm (2006) 1.86
Regional left atrial voltage in patients with atrial fibrillation. Heart Rhythm (2006) 1.84
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res (2011) 1.65
Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol (2014) 1.56
Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation (2015) 1.55
Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1. Cardiovasc Res (2013) 1.55
Heart failure decreases nerve activity in the right atrial ganglionated plexus. J Cardiovasc Electrophysiol (2011) 1.46
Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts. J Mol Cell Cardiol (2011) 1.34
Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts. Eur Heart J (2015) 1.21
P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey. Heart Rhythm (2010) 1.09
Arrhythmias and vagus nerve stimulation. Heart Fail Rev (2011) 1.07
Atrial fibrillation in congestive heart failure. Heart Fail Clin (2010) 1.07
Electrophysiological remodeling in heart failure. J Mol Cell Cardiol (2010) 1.05
The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study. Am Heart J (2011) 1.03
Genetics of atrial fibrillation: implications for future research directions and personalized medicine. Circ Arrhythm Electrophysiol (2010) 1.01
Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study. Circ Arrhythm Electrophysiol (2012) 0.98
Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther (2011) 0.94
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication. J Arrhythm (2016) 0.94
Ca2+ clock malfunction in a canine model of pacing-induced heart failure. Am J Physiol Heart Circ Physiol (2010) 0.93
Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart. Circulation (2016) 0.93
Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping. Circulation (2014) 0.92
Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.92
Cardioversion of atrial fibrillation or atrial flutter into sinus rhythm reduces nocturnal central respiratory events and unmasks obstructive sleep apnoea. Clin Res Cardiol (2015) 0.89
Common SCN10A variants modulate PR interval and heart rate response during atrial fibrillation. Europace (2013) 0.89
Mechano-sensitivity of cardiac pacemaker function: pathophysiological relevance, experimental implications, and conceptual integration with other mechanisms of rhythmicity. Prog Biophys Mol Biol (2012) 0.88
Influence of race on atrial fibrillation after cardiac surgery. Circ Arrhythm Electrophysiol (2011) 0.87
Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart (2005) 0.85
Atrial arrhythmia in ageing spontaneously hypertensive rats: unraveling the substrate in hypertension and ageing. PLoS One (2013) 0.84
Renal denervation: effects on atrial electrophysiology and arrhythmias. Clin Res Cardiol (2014) 0.84
P-wave indices and atrial fibrillation: cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study. Am Heart J (2014) 0.83
Comparison of left atrial electrophysiologic abnormalities during sinus rhythm in patients with different type of atrial fibrillation. J Interv Card Electrophysiol (2013) 0.82
Hypertrophic reprogramming of the left ventricle: translation to the ECG. J Electrocardiol (2012) 0.82
Effect of transcatheter aortic valve replacement on P-wave duration, P-wave dispersion and left atrial size. J Geriatr Cardiol (2015) 0.82
High concentrations of omega-3 fatty acids are associated with the development of atrial fibrillation in the Japanese population. Heart Vessels (2012) 0.81
The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay. Pulm Med (2013) 0.80
The prognostic impact of successful cardioversion of atrial fibrillation in patients with organic heart disease. Clin Res Cardiol (2006) 0.80
Prediction of atrial fibrillation development and progression: Current perspectives. World J Cardiol (2016) 0.80
Arrhythmia risk in liver cirrhosis. World J Hepatol (2015) 0.79
Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times? Cardiovasc Res (2009) 0.79
Early management of atrial fibrillation: from imaging to drugs to ablation. Nat Rev Cardiol (2010) 0.78
Resynchronization therapy in the context of atrial fibrillation: benefits and limitations. J Interv Card Electrophysiol (2007) 0.77
Congestive Heart Failure Leads to Prolongation of the PR Interval and Atrioventricular Junction Enlargement and Ion Channel Remodelling in the Rabbit. PLoS One (2015) 0.77
The impact of hypertension on the electromechanical properties and outcome of catheter ablation in atrial fibrillation patients. J Thorac Dis (2014) 0.77
P wave area for quantitative electrocardiographic assessment of left atrial remodeling. PLoS One (2014) 0.77
Prevalence of isolated atrial amyloidosis in young patients affected by congestive heart failure. ScientificWorldJournal (2012) 0.76
Filtered signal-averaged P-wave duration during pneumoperitoneum in patients undergoing laparoscopic cholecystectomy: A reflection of pathophysiological cardiac changes. Surg Endosc (2007) 0.76
Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol (2015) 0.76
A multidimensional sight on cardiac failure: uncovered from structural to molecular level. Heart Fail Rev (2017) 0.75
Heart failure modulates electropharmacological characteristics of sinoatrial nodes. Exp Ther Med (2016) 0.75
Radiofrequency Ablation of Persistent Atrial Fibrillation: Diagnosis-to-Ablation Time, Markers of Pathways of Atrial Remodeling, and Outcomes. Circ Arrhythm Electrophysiol (2016) 0.75
Atrial fibrillation. CMAJ (2004) 0.75
Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure. Clin Med Insights Cardiol (2016) 0.75
SR calcium handling dysfunction, stress-response signaling pathways, and atrial fibrillation. Front Physiol (2015) 0.75
Association between Postoperatively Developed Atrial Fibrillation and Long-Term Mortality after Esophagectomy in Esophageal Cancer Patients: An Observational Study. PLoS One (2016) 0.75
Atrial fibrillation recurrence predictors after conversion to sinus rhythm. Curr Health Sci J (2014) 0.75
Electroanatomic contact mapping: how to use optimally to recognise the arrhythmia mechanism? Indian Pacing Electrophysiol J (2010) 0.75
Catheter ablation of persistent atrial fibrillation: The importance of substrate modification. World J Cardiol (2015) 0.75
Impact of pre-existent areas of complex fractionated atrial electrograms on outcome after pulmonary vein isolation. J Interv Card Electrophysiol (2008) 0.75
Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times. Korean Circ J (2017) 0.75
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res (2017) 0.75
"Window Sliding" analysis combined with high-density and rapid electroanatomical mapping: its efficacy and the outcome of catheter ablation of atrial tachycardia. Heart Vessels (2017) 0.75
Impaired adaptation to left atrial pressure increase in patients with atrial fibrillation. J Interv Card Electrophysiol (2015) 0.75
Reconstructing the early evolution of Fungi using a six-gene phylogeny. Nature (2006) 8.94
Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol (2013) 3.08
The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol (2010) 2.56
P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol (2006) 2.47
Cardiovascular effects of marine omega-3 fatty acids. Lancet (2010) 2.45
Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol (2012) 2.40
Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J (2013) 2.29
Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm (2005) 2.07
Prevalence of fractionated electrograms in the coronary sinus: comparison between patients with persistent or paroxysmal atrial fibrillation and a control population. Heart Rhythm (2010) 2.04
Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol (2004) 1.84
Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm (2011) 1.80
Influence of age and gender on the mechanism of supraventricular tachycardia. Heart Rhythm (2004) 1.79
Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm (2011) 1.74
Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J (2006) 1.73
Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol (2012) 1.70
Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve. Circulation (2004) 1.70
Effect of respiration on catheter-tissue contact force during ablation of atrial arrhythmias. Heart Rhythm (2012) 1.67
The challenge of endocardial right ventricular pacing in patients with a tricuspid annuloplasty ring and severe tricuspid regurgitation. Pacing Clin Electrophysiol (2002) 1.67
Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Heart Rhythm (2011) 1.62
Electrophysiological and electroanatomic characterization of the atria in sinus node disease: evidence of diffuse atrial remodeling. Circulation (2004) 1.62
Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia. J Am Coll Cardiol (2009) 1.61
Anatomically determined functional conduction delay in the posterior left atrium relationship to structural heart disease. J Am Coll Cardiol (2008) 1.58
Relationship among complex signals, short cycle length activity, and dominant frequency in patients with long-lasting persistent AF: a high-density epicardial mapping study in humans. Heart Rhythm (2011) 1.55
Supraventricular tachycardia. Med J Aust (2009) 1.54
Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis (2011) 1.53
An evidence-based consensus for the classification of arbuscular mycorrhizal fungi (Glomeromycota). Mycorrhiza (2013) 1.53
Left atrial remodeling in patients with atrial septal defects. Heart Rhythm (2009) 1.52
Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial electrophysiology. Heart Rhythm (2010) 1.52
Esophageal hematoma after atrial fibrillation ablation: incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol (2012) 1.50
Scar-related right atrial macroreentrant tachycardia in patients without prior atrial surgery: electroanatomic characterization and ablation outcome. Heart Rhythm (2005) 1.49
The role of chronic atrial stretch and atrial fibrillation on posterior left atrial wall conduction. Heart Rhythm (2009) 1.48
Pacemaker mediated tachycardia as a complication of the autointrinsic conduction search function. Pacing Clin Electrophysiol (2004) 1.48
Characterization of catheter-tissue contact force during epicardial radiofrequency ablation in an ovine model. Circ Arrhythm Electrophysiol (2013) 1.46
Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm (2013) 1.44
The transesophageal echo probe may contribute to esophageal injury after catheter ablation for paroxysmal atrial fibrillation under general anesthesia: a preliminary observation. J Cardiovasc Electrophysiol (2014) 1.44
Atrial fibrillation following lung transplantation: double but not single lung transplant is associated with long-term freedom from paroxysmal atrial fibrillation. Eur Heart J (2010) 1.43
Absence of gender-based differences in the atrial and pulmonary vein substrate: a detailed electroanatomic mapping study. J Cardiovasc Electrophysiol (2014) 1.42
Pulmonary vein paced activation sequence mapping: comparison with activation sequences during onset of focal atrial fibrillation. J Cardiovasc Electrophysiol (2002) 1.41
Idiopathic epicardial left ventricular tachycardia originating remote from the sinus of Valsalva: electrophysiological characteristics, catheter ablation, and identification from the 12-lead electrocardiogram. Circulation (2006) 1.39
Bipolar electrogram shannon entropy at sites of rotational activation: implications for ablation of atrial fibrillation. Circ Arrhythm Electrophysiol (2012) 1.32
Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol (2012) 1.29
Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol (2009) 1.26
Arbuscular mycorrhizal communities in tropical forests are affected by host tree species and environment. Oecologia (2003) 1.25
Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation (2003) 1.22
Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization. J Am Coll Cardiol (2003) 1.21
Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2007) 1.20
Catheter ablation of atrial arrhythmias: state of the art. Lancet (2012) 1.18
Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation. J Cardiovasc Electrophysiol (2007) 1.17